North America AI In Drug Repurposing Market Size, Share & Industry Analysis Report By Component, By Technology, By End Use, By Application, By Country and Growth Forecast, 2025

List of Tables

The North America AI In Drug Repurposing Market would witness market growth of 19.2% CAGR during the forecast period (2025-2032).

The US market dominated the North America AI In Drug Repurposing Market by Country in 2024, and would continue to be a dominant market till 2032; thereby, achieving a market value of $1,311.4 million by 2032. The Canada market is experiencing a CAGR of 21.8% during (2025 - 2032). Additionally, The Mexico market would exhibit a CAGR of 21.8% during (2025 - 2032). The US and Canada led the North America AI In Drug Repurposing Market by Country with a market share of 81.9% and 11% in 2024.

North America has become a global center for using artificial intelligence in drug discovery and repurposing. This is thanks to its strong research and development infrastructure, large biomedical datasets, and strong regulatory bodies. Digital health records and genomics databases sped up the shift from manually repurposing drugs to AI-driven modeling. This helped researchers and startups find new drug-disease connections. Collaborations between AI companies and big drug companies in innovation hubs like Boston and Silicon Valley have turned AI repurposing from an academic field into a commercialized, clinical-stage field. This is because of access to proprietary data, computational power, and knowledge of regulations.

Some of the most important trends in this ecosystem are the use of real-world evidence to improve predictive validation, the rise of explainable AI to meet regulatory and scientific standards for openness, and the growing focus on rare diseases, which is supported by North American orphan drug policies. Competitive strategies focus on forming deep co-development partnerships with pharmaceutical research and development, creating unique data assets, and using hybrid business models that combine licensing with developing assets in-house. As competition heats up between AI-biotech companies, pharmaceutical divisions, and new tech companies, success depends more and more on combining biological insight, data exclusivity, model interpretability, and clinical validation to make sure that the results are useful and accepted by regulators.

Technology Outlook

Based on Technology, the market is segmented into Machine Learning/Deep Learning, Natural Language Processing (NLP), Knowledge Graphs & Network-Based AI, Generative AI & Large Language Models (LLMs), and Computer Vision. The Machine Learning/Deep Learning market segment dominated the US AI In Drug Repurposing Market by Technology is expected to grow at a CAGR of 17.2 % during the forecast period thereby continuing its dominance until 2032. Also, The Computer Vision market is anticipated to grow as a CAGR of 22.6 % during the forecast period during (2025 - 2032).

End Use Outlook

Based on End Use, the market is segmented into Pharmaceutical & BioTechnology Companies, Contract Research Organizations (CROs), Academic & Research Institutes, and Other End Use. Among various Canada AI In Drug Repurposing Market by End Use; The Pharmaceutical & BioTechnology Companies market achieved a market size of USD $27.1 Million in 2024 and is expected to grow at a CAGR of 21.3 % during the forecast period. The Academic & Research Institutes market is predicted to experience a CAGR of 22.7% throughout the forecast period from (2025 - 2032).

Country Outlook

The US is the leader in the global AI drug repurposing market because of its advanced biotech ecosystem, strong pharmaceutical infrastructure, and culture of quick innovation. Strong partnerships between AI developers, pharmaceutical companies, and research institutions, backed by large biomedical data and government programs, have sped up the use of AI in drug discovery and repurposing. The market is moving toward platform-based models that use deep learning and network biology. There is also a growing focus on explainable AI and real-world evidence. Even though there are problems like data privacy and gaps in clinical validation, growth is still happening thanks to strategic partnerships and open regulations. So, the U.S. is the most important place for technological and scientific progress in AI-driven drug repurposing.

List of Key Companies Profiled

Ginkgo Bioworks Holdings, Inc.
IBM Corporation
Atomwise, Inc.
Cyclica, Inc.
Genesis Healthcare Co.
Verge, Inc.
Novartis AG
Schrodinger, Inc
Recursion Pharmaceuticals, Inc.
The Cradle Company

North America AI In Drug Repurposing Market Report Segmentation

By Component

Software & Platform
Services

By Technology

Machine Learning/Deep Learning
Natural Language Processing (NLP)
Knowledge Graphs & Network-Based AI
Generative AI & Large Language Models (LLMs)
Computer Vision

By End Use

Pharmaceutical & BioTechnology Companies
Contract Research Organizations (CROs)
Academic & Research Institutes
Other End Use

By Application

Oncology
Neurology
Infectious Diseases
Rare & Orphan Diseases
Cardiology
Other Application

By Country

US
Canada
Mexico
Rest of North America

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America AI In Drug Repurposing Market, by Component
- 1.4.2 North America AI In Drug Repurposing Market, by Technology
- 1.4.3 North America AI In Drug Repurposing Market, by End Use
- 1.4.4 North America AI In Drug Repurposing Market, by Application
- 1.4.5 North America AI In Drug Repurposing Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Market Trends - North America AI In Drug Repurposing Market

Chapter 5. State of Competition - North America AI in Drug Repurposing Market

Chapter 6. Value Chain Analysis of AI In Drug Repurposing Market

Chapter 7. Product Life Cycle - AI In Drug Repurposing Market

Chapter 8. Market Consolidation - AI In Drug Repurposing Market

Chapter 9. Key Customer Criteria - AI In Drug Repurposing Market

Chapter 10. North America AI In Drug Repurposing Market by Component

10.1 North America Software & Platform Market by Country
10.2 North America Services Market by Country

Chapter 11. North America AI In Drug Repurposing Market by Technology

11.1 North America Machine Learning/Deep Learning Market by Region
11.2 North America Natural Language Processing (NLP) Market by Region
11.3 North America Knowledge Graphs & Network-Based AI Market by Region
11.4 North America Generative AI & Large Language Models (LLMs) Market by Region
11.5 North America Computer Vision Market by Region

Chapter 12. North America AI In Drug Repurposing Market by End Use

12.1 North America Pharmaceutical & BioTechnology Companies Market by Country
12.2 North America Contract Research Organizations (CROs) Market by Country
12.3 North America Academic & Research Institutes Market by Country
12.4 North America Other End Use Market by Country

Chapter 13. North America AI In Drug Repurposing Market by Application

13.1 North America Oncology Market by Country
13.2 North America Neurology Market by Country
13.3 North America Infectious Diseases Market by Country
13.4 North America Rare & Orphan Diseases Market by Country
13.5 North America Cardiology Market by Country
13.6 North America Other Application Market by Country

Chapter 14. North America AI In Drug Repurposing Market by Country

14.1 US AI In Drug Repurposing Market
- 14.1.1 US AI In Drug Repurposing Market by Component
- 14.1.2 US AI In Drug Repurposing Market by Technology
- 14.1.3 US AI In Drug Repurposing Market by End Use
- 14.1.4 US AI In Drug Repurposing Market by Application
14.2 Canada AI In Drug Repurposing Market
- 14.2.1 Canada AI In Drug Repurposing Market by Component
- 14.2.2 Canada AI In Drug Repurposing Market by Technology
- 14.2.3 Canada AI In Drug Repurposing Market by End Use
- 14.2.4 Canada AI In Drug Repurposing Market by Application
14.3 Mexico AI In Drug Repurposing Market
- 14.3.1 Mexico AI In Drug Repurposing Market by Component
- 14.3.2 Mexico AI In Drug Repurposing Market by Technology
- 14.3.3 Mexico AI In Drug Repurposing Market by End Use
- 14.3.4 Mexico AI In Drug Repurposing Market by Application
14.4 Rest of North America AI In Drug Repurposing Market
- 14.4.1 Rest of North America AI In Drug Repurposing Market by Component
- 14.4.2 Rest of North America AI In Drug Repurposing Market by Technology
- 14.4.3 Rest of North America AI In Drug Repurposing Market by End Use
- 14.4.4 Rest of North America AI In Drug Repurposing Market by Application

Chapter 15. Company Profiles

15.1 Ginkgo Bioworks Holdings, Inc.
- 15.1.1 Company Overview
- 15.1.2 Financial Analysis
- 15.1.3 Segmental and Regional Analysis
- 15.1.4 Research & Development Expenses
- 15.1.5 Recent strategies and developments:
  - 15.1.5.1 Partnerships, Collaborations, and Agreements:
- 15.1.6 SWOT Analysis
15.2 IBM Corporation
- 15.2.1 Company Overview
- 15.2.2 Financial Analysis
- 15.2.3 Regional & Segmental Analysis
- 15.2.4 Research & Development Expenses
- 15.2.5 Recent strategies and developments:
  - 15.2.5.1 Partnerships, Collaborations, and Agreements:
- 15.2.6 SWOT Analysis
15.3 Atomwise, Inc.
- 15.3.1 Company Overview
15.4 Cyclica, Inc.
- 15.4.1 Company Overview
15.5 Genesis Healthcare Co.
- 15.5.1 Company Overview
15.6 Verge, Inc.
- 15.6.1 Company Overview
15.7 Novartis AG
- 15.7.1 Company Overview
- 15.7.2 Financial Analysis
- 15.7.3 Segmental and Regional Analysis
- 15.7.4 Research & Development Expenses
- 15.7.5 SWOT Analysis
15.8 Schrodinger, Inc
- 15.8.1 Company Overview
- 15.8.2 Financial Analysis
- 15.8.3 Segmental and Regional Analysis
- 15.8.4 Research & Development Expenses
15.9 Recursion Pharmaceuticals, Inc.
- 15.9.1 Company Overview
- 15.9.2 Financial Analysis
- 15.9.3 Research & Development Expenses
15.10. The Cradle Company
- 15.10.1 Company Overview

LIST OF TABLES

TABLE 1 North America AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 2 North America AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 3 Key Customer Criteria and Ratings for AI in Drug Repurposing Market
TABLE 4 North America AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 5 North America AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 6 North America Software & Platform Market by Country, 2021 - 2024, USD Million
TABLE 7 North America Software & Platform Market by Country, 2025 - 2032, USD Million
TABLE 8 North America Services Market by Country, 2021 - 2024, USD Million
TABLE 9 North America Services Market by Country, 2025 - 2032, USD Million
TABLE 10 North America AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 11 North America AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 12 North America Machine Learning/Deep Learning Market by Region, 2021 - 2024, USD Million
TABLE 13 North America Machine Learning/Deep Learning Market by Region, 2025 - 2032, USD Million
TABLE 14 North America Natural Language Processing (NLP) Market by Region, 2021 - 2024, USD Million
TABLE 15 North America Natural Language Processing (NLP) Market by Region, 2025 - 2032, USD Million
TABLE 16 North America Knowledge Graphs & Network-Based AI Market by Region, 2021 - 2024, USD Million
TABLE 17 North America Knowledge Graphs & Network-Based AI Market by Region, 2025 - 2032, USD Million
TABLE 18 North America Generative AI & Large Language Models (LLMs) Market by Region, 2021 - 2024, USD Million
TABLE 19 North America Generative AI & Large Language Models (LLMs) Market by Region, 2025 - 2032, USD Million
TABLE 20 North America Computer Vision Market by Region, 2021 - 2024, USD Million
TABLE 21 North America Computer Vision Market by Region, 2025 - 2032, USD Million
TABLE 22 North America AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 23 North America AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 24 North America Pharmaceutical & BioTechnology Companies Market by Country, 2021 - 2024, USD Million
TABLE 25 North America Pharmaceutical & BioTechnology Companies Market by Country, 2025 - 2032, USD Million
TABLE 26 North America Contract Research Organizations (CROs) Market by Country, 2021 - 2024, USD Million
TABLE 27 North America Contract Research Organizations (CROs) Market by Country, 2025 - 2032, USD Million
TABLE 28 North America Academic & Research Institutes Market by Country, 2021 - 2024, USD Million
TABLE 29 North America Academic & Research Institutes Market by Country, 2025 - 2032, USD Million
TABLE 30 North America Other End Use Market by Country, 2021 - 2024, USD Million
TABLE 31 North America Other End Use Market by Country, 2025 - 2032, USD Million
TABLE 32 North America AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 33 North America AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 34 North America Oncology Market by Country, 2021 - 2024, USD Million
TABLE 35 North America Oncology Market by Country, 2025 - 2032, USD Million
TABLE 36 North America Neurology Market by Country, 2021 - 2024, USD Million
TABLE 37 North America Neurology Market by Country, 2025 - 2032, USD Million
TABLE 38 North America Infectious Diseases Market by Country, 2021 - 2024, USD Million
TABLE 39 North America Infectious Diseases Market by Country, 2025 - 2032, USD Million
TABLE 40 North America Rare & Orphan Diseases Market by Country, 2021 - 2024, USD Million
TABLE 41 North America Rare & Orphan Diseases Market by Country, 2025 - 2032, USD Million
TABLE 42 North America Cardiology Market by Country, 2021 - 2024, USD Million
TABLE 43 North America Cardiology Market by Country, 2025 - 2032, USD Million
TABLE 44 North America Other Application Market by Country, 2021 - 2024, USD Million
TABLE 45 North America Other Application Market by Country, 2025 - 2032, USD Million
TABLE 46 North America AI In Drug Repurposing Market by Country, 2021 - 2024, USD Million
TABLE 47 North America AI In Drug Repurposing Market by Country, 2025 - 2032, USD Million
TABLE 48 US AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 49 US AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 50 US AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 51 US AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 52 US AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 53 US AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 54 US AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 55 US AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 56 US AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 57 US AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 58 Canada AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 59 Canada AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 60 Canada AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 61 Canada AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 62 Canada AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 63 Canada AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 64 Canada AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 65 Canada AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 66 Canada AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 67 Canada AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 68 Mexico AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 69 Mexico AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 70 Mexico AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 71 Mexico AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 72 Mexico AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 73 Mexico AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 74 Mexico AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 75 Mexico AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 76 Mexico AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 77 Mexico AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 78 Rest of North America AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 79 Rest of North America AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 80 Rest of North America AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 81 Rest of North America AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 82 Rest of North America AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 83 Rest of North America AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 84 Rest of North America AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 85 Rest of North America AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 86 Rest of North America AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 87 Rest of North America AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 88 Key Information - GINKGO BIOWORKS HOLDINGS, INC.
TABLE 89 Key Information - IBM Corporation
TABLE 90 Key Information - Atomwise, Inc.
TABLE 91 Key Information - Cyclica, Inc.
TABLE 92 Key Information - Genesis Healthcare Co.
TABLE 93 Key Information - Verge, Inc.
TABLE 94 Key Information - Novartis AG
TABLE 95 Key Information - Schrodinger, Inc
TABLE 96 Key Information - Recursion Pharmaceuticals, Inc.
TABLE 97 Key Information - The Cradle Company

LIST OF FIGURES

FIG 1 Methodology for the research
FIG 2 North America AI In Drug Repurposing Market, 2021 - 2032, USD Million
FIG 3 Key Factors Impacting north America AI In Drug Repurposing Market
FIG 4 Porter's Five Forces Analysis - AI In Drug Repurposing Market
FIG 5 Value Chain Analysis of AI In Drug Repurposing Market
FIG 6 Product Life Cycle - AI In Drug Repurposing Market
FIG 7 Market Consolidation - AI In Drug Repurposing Market
FIG 8 Key Customer Criteria - AI In Drug Repurposing Market
FIG 9 North America AI In Drug Repurposing Market share by Component, 2024
FIG 10 North America AI In Drug Repurposing Market share by Component, 2032
FIG 11 North America AI In Drug Repurposing Market by Component, 2021 - 2032, USD Million
FIG 12 North America AI In Drug Repurposing Market share by Technology, 2024
FIG 13 North America AI In Drug Repurposing Market share by Technology, 2032
FIG 14 North America AI In Drug Repurposing Market by Technology, 2021 - 2032, USD Million
FIG 15 North America AI In Drug Repurposing Market share by End Use, 2024
FIG 16 North America AI In Drug Repurposing Market share by End Use, 2032
FIG 17 North America AI In Drug Repurposing Market by End Use, 2021 - 2032, USD Million
FIG 18 North America AI In Drug Repurposing Market share by Application, 2024
FIG 19 North America AI In Drug Repurposing Market share by Application, 2032
FIG 20 North America AI In Drug Repurposing Market by Application, 2021 - 2032, USD Million
FIG 21 North America AI In Drug Repurposing Market share by Country, 2024
FIG 22 North America AI In Drug Repurposing Market share by Country, 2032
FIG 23 North America AI In Drug Repurposing Market by Country, 2021 - 2032, USD Million
FIG 24 Swot Analysis: Ginkgo Bioworks
FIG 25 SWOT Analysis: IBM Corporation
FIG 26 SWOT Analysis: Novartis AG

North America AI In Drug Repurposing Market Size, Share & Industry Analysis Report By Component, By Technology, By End Use, By Application, By Country and Growth Forecast, 2025 - 2032

Description

Table of Contents